Effects of Cellular Methylation on Transgene Expression and Site-Specific Integration of Adeno-Associated Virus
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
DNA methylation is a major epigenetic event that affects not only cellular gene expression but that also has the potential to influence bacterial and viral DNA in their host-dependent functions. Adeno-associated virus (AAV) genome contains a high degree of CpG sequences capable of methylation in its terminal repeat sequences, which are the sole elements retained in AAV-based vectors used in gene therapy. The present study determined the influence of methylation status of the host cell on wild type (wt) AAV integration and recombinant (r) AAV transgene expression in HeLa cells. Results of the study indicated that hypo-methylation significantly enhanced both wtAAV chromosomal integration and transgene expression of rAAV. A direct influence of methylation on AAV integration was further confirmed by methylating the AAVS1 integration sites prior to viral infection with DNA trans-complementation assay. These results signify the importance of epigenetic status of target cells as one of the key factors in long-term transgene expression in AAV gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Effect of de novo AAVS1 methylation on wtAAV site-specific integration. C18 cells were transfected with unmethylated and in vitro methylated p220.2 plasmids containing the 8.2 kb human AAVS1 and infected with wtAAV. Low molecular DNA was isolated by Hirt method [23] from mock, unmethylated and methylated AAVS1 transfected C18 cells and subjected to nested-PCR analysis. PCR products were separated by electrophoresis and subjected to Southern hybridization using a P32-labeled probe against AAV-inverted terminal repeat (ITR) and AAVS1. DNA from Detroit-6 cells was used as a control.](https://figures.cochat.ai/paper-figures/916f5f62c1524d509155491c9bba8eaa/effects-of-cellular-methylation-on-transgene-expression-and-site-specific-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies indicated that the reduction of CpG islands in rAAV vectors increased transgene expression and reduced TLR9-mediated innate immune detection [46,47].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,146
CpG islands and the regulation of transcription
Deaton, A. M., & Bird, A. (2011) · Genes & Development · doi:10.1101/gad.2037511 · Cited by 3,187
MethPrimer: designing primers for methylation PCRs
Li, L.-C., & Dahiya, R. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.11.1427 · Cited by 2,729
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
Bauer, S., Kirschning, C. J., Häcker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., & Lipford, G. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161293498 · Cited by 1,533
Christman, J. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205699 · Cited by 1,525
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Site-specific integration by adeno-associated virus.
Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., & Berns, K. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2211 · Cited by 868
Site-specific integration by adeno-associated virus.
Linden, R. M., Ward, P., Giraud, C., Winocour, E., & Berns, K. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11288 · Cited by 805
Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3227-3234.1996 · Cited by 761 · cited 2×
“Moreover, second-strand synthesis is ratelimiting for both AAV replication and transgene expression [26].”
BackgroundSelf-complementary AAV vectors; advances and applications
McCarty, D. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.171 · Cited by 515
Integration of Adeno-Associated Virus (AAV) and Recombinant AAV Vectors
McCarty, D. M., Young, S. M., & Samulski, R. J. (2004) · Annual Review of Genetics · doi:10.1146/annurev.genet.37.110801.143717 · Cited by 450
Brooks, A. R., Harkins, R. N., Wang, P., Qian, H. S., Liu, P., & Rubanyi, G. M. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.516 · Cited by 362
Karlin, S., Doerfler, W., & Cardon, L. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.2889-2897.1994 · Cited by 326
Immune Responses to AAV in Clinical Trials
Mingozzi, F., & A. High, K. (2011) · Current Gene Therapy · doi:10.2174/156652311796150354 · Cited by 324
Immune Responses to AAV in Clinical Trials
Mingozzi, F., & High, K. (2007) · Current Gene Therapy · doi:10.2174/156652307782151425 · Cited by 238
Lynch, M. D., Smith, A. J. H., De Gobbi, M., Flenley, M., Hughes, J. R., Vernimmen, D., Ayyub, H., Sharpe, J. A., Sloane‐Stanley, J. A., Sutherland, L., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.399 · Cited by 194
Schlehofer, J. R., Ehrbar, M., & Hausen, H. Z. (1986) · Virology · doi:10.1016/0042-6822(86)90376-4 · Cited by 186
Silencing of gene expression: implications for design of retrovirus vectors
Pannell, D., & Ellis, J. (2001) · Reviews in Medical Virology · doi:10.1002/rmv.316 · Cited by 174
Jaenisch, R., Schnieke, A., & Harbers, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.5.1451 · Cited by 141
Ponnazhagan, S., Mahendra, G., Kumar, S., Thompson, J. A., & Castillas (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12900-12907.2002 · Cited by 129
Self-citationSequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats
Ryan, J. H., Zolotukhin, S., & Muzyczka, N. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1542-1553.1996 · Cited by 119
Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence.
Giraud, C., Winocour, E., & Berns, K. I. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.10039 · Cited by 117
Direct Immunologic activities of CpG DNA and implications for gene therapy
Krieg, A. Μ. (1999) · The Journal of Gene Medicine · Cited by 117
Finn, J. D., Hui, D., Downey, H. D., Dunn, D., Pien, G. C., Mingozzi, F., Zhou, S., & High, K. A. (2010) · Molecular Therapy · doi:10.1038/mt.2009.257 · Cited by 115
Łuszczek, W., Cheriyath, V., Mekhail, T. M., & Borden, E. C. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0309 · Cited by 94
Hermonat, P. L. (1994) · PubMed · Cited by 90
Lamartina, S., Roscilli, G., Rinaudo, D., Delmastro, P., & Toniatti, C. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7653-7658.1998 · Cited by 56
Selective uptake and sustained expression of AAV vectors following subcutaneous delivery
Donahue, B. A., McArthur, J. G., Spratt, S. K., Bohl, D., Lagarde, C., Sanchez, L., Kaspar, B., Sloan, B. A., Lee, Y. L., Danos, O., et al. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199901/02)1:1<31::aid-jgm3>3.0.co;2-t · Cited by 49
Present and Future of Adeno Associated Virus Based Gene Therapy Approaches
Ortolano, S., Spuch, C., & Navarro, C. (2012) · Recent Patents on Endocrine, Metabolic & Immune Drug Discovery · doi:10.2174/187221412799015245 · Cited by 35
Doerfler, W. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.698 · Cited by 30
Ren, C., Kumar, S., Shaw, D. R., & Ponnazhagan, S. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1047 · Cited by 29
Self-citation
Cited by
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
Buck, T., & Wijnholds, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124197 · Cited by 92
“Recent studies indicated that the reduction of CpG islands in rAAV vectors increased transgene expression and reduced TLR9-mediated innate immune detection [46,47].”
BackgroundEpigenetic Silencing of Recombinant Adeno-associated Virus Genomes by NP220 and the HUSH Complex
Das, A., Vijayan, M., Walton, E. M., Stafford, V. G., Fiflis, D. N., & Asokan, A. (2021) · Journal of Virology · doi:10.1128/jvi.02039-21 · Cited by 71
Lysosomal diseases: Overview on current diagnosis and treatment
Poswar, F. D. O., Vairo, F. P. E., Burin, M. G., Michelin‐Tirelli, K., Brusius‐Facchin, A. C., Kubaski, F., de Souza, C. F. M., Baldo, G., & Giugliani, R. (2019) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2018-0159 · Cited by 72
Targeted long-read sequencing captures CRISPR editing and AAV integration outcomes in brain
Simpson, B. P., Yrigollen, C. M., Izda, A., & Davidson, B. L. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.01.004 · Cited by 56
Metadata
- Authors
- Chanda, D., Hensel, J., Higgs, J., Grover, R., Kaza, N., & Ponnazhagan, S.
- Affiliations
- University of Alabama at Birmingham (US)
- Corresponding author
- Ponnazhagan, Selvarangan
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2017-09-18
- Volume
- 8
- Issue
- 9
- Pages
- 232
- ISSN
- 2073-4425 (ISSN-L)
- PMC
- PMC5615365
- OpenAlex
- W2755707343
- Cited by
- 19
- References
- 31
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 1
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Genes (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health (AR60948, CA132077, CA133737, CA184770)
- U.S. Department of Defense (PR141945)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- DNA methylation, adeno-associated virus, AAV integration, CpG sequences, transgene expression, gene therapy vectors, epigenetics, HeLa cells, hypomethylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.